The cost of managing genital warts in the UK

International Journal of STD & AIDS
T LanitisR E Brown

Abstract

The national cost of managing genital warts (GWs) in the UK has not been fully estimated, yet is required to inform decisions on vaccination against human papillomavirus. This study estimated the 2010 UK costs based on secondary genitourinary (GU) medicine clinic data from the Health Protection Agency (HPA) and primary care data from the Health Improvement Network database. Extrapolating data to 2010 resulted in 173,077 GU medicine clinic and 16,782 primary care GW episodes. Using treatment patterns obtained from key opinion leaders and tariffs from National Health Service Payment by Results (NHS PbR), the national costs were estimated at £52.4 million: £276 per treated GW episode.

References

Apr 28, 1990·BMJ : British Medical Journal·J Chisholm
Jul 2, 2004·International Journal of STD & AIDS·Paul C LangleySusan M Drake
Aug 17, 2004·International Journal of STD & AIDS·Paul C LangleySusan M Drake
May 11, 2006·Current Medical Research and Opinion·R E BrownS Bénard
Nov 14, 2008·Sexually Transmitted Infections·A DeeK Hunter
Jun 4, 2011·Sexually Transmitted Infections·S C WoodhallUNKNOWN QOLIGEN study group
Aug 5, 2011·Sexually Transmitted Infections·Sarika DesaiKate Soldan

❮ Previous
Next ❯

Citations

May 3, 2013·Virology Journal·Matthew G HawkinsPeter K C Goon
Oct 17, 2015·Drug and Therapeutics Bulletin
Sep 9, 2017·Journal of the Royal Army Medical Corps·William M J SharpN E Dufty
Mar 14, 2013·Sexually Transmitted Diseases·Basil Donovan, Rebecca J Guy

❮ Previous
Next ❯

Software Mentioned

QOLIGEN

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Sexually Transmitted Infections
Sarika DesaiKate Soldan
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
Keshwar BaboolalKaren Wilson
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Maria BlombergSusanne K Kjaer
© 2021 Meta ULC. All rights reserved